Madrigal Appoints Jacqualyn A. Fouse, Ph.D.
Portfolio Pulse from
Madrigal Pharmaceuticals has appointed Jacqualyn A. Fouse, Ph.D., to its Board of Directors, while Fred Craves, Ph.D., will retire from the board in July 2025.
March 11, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Madrigal Pharmaceuticals has announced a leadership change with the appointment of Jacqualyn A. Fouse, Ph.D., to its Board of Directors. Fred Craves, Ph.D., will retire in July 2025.
The appointment of a new board member and the planned retirement of an existing one are significant governance changes. However, these changes are not expected to have an immediate impact on the stock price, hence a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 80